Participations à des congrès et colloques internationaux (137)
90.
Goole, J., Vanderbist, F., & Amighi, K. (2008). Evaluation and floating enhancement of L-Dopa sustained-release floating minitablets coated with Eudragit® RL30D. 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology Abstract session presented at (Barcelona)
91.
Goole, J., Vanderbist, F., & Amighi, K. (2008). Evaluation and floating enhancement of L-Dopa sustained release floating minitablets coated with Eudragit RL30D. Poster présenté à la conférence 6th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology (7th-10th April 2008: Barcelona, Spain).
92.
Goole, J., Vanderbist, F., & Amighi, K. (2007). Development and evaluation of new floating levodopa sustained release minitablets. 34th Annual meeting & Exposition of the Controlled Release Society Abstract session presented at 34th Annual meeting & Exposition of the Controlled Release Society(Long Beach, USA)
93.
Goole, J., Vanderbist, F., & Amighi, K. (2007). Development and evaluation of new multiple-unit sustained-release floating systems. Société Belge des Sciences Pharmaceutiques Abstract session presented at (Spa)
94.
Goole, J., Vanderbist, F., & Amighi, K. (2007). Développement et évaluation de nouvelles formes pharmaceutiques flottantes à libération prolongée. Journée de l’école doctorale Abstract session presented at (ULB)
95.
Goole, J., Vanderbist, F., & Amighi, K. (2007). Development and evaluation of new floating levodopa sustained-release dosage form. Poster présenté à la conférence 34th Annual meeting & Exposition of the Controlled Release Society (Long Beach USA).
96.
Pilcer, G., Vanderbist, F., & Amighi, K. (2007). Lung deposition and pharmacokinetic of tobramycin dry powder formulations in cystic fibrosis. Paper session presented at 34th Annual Meeting & Exposition of the controlled release society (July 7-11, 2007: Long Beach, California U.S.A).
97.
Pilcer, G., & Amighi, K. (2007). Development and in vivo evaluation of dry powder tobramycin formulations in the cystic fibrosis treatment. Paper session presented at 13th Forum of Pharmaceutical Sciences (11-12 October 2007: Spa, Belgium).
98.
Pilcer, G., & Amighi, K. (2007). La Tobramycine inhalée: Nébulisation versus poudre sèche. Paper session presented at La mucoviscidose au quotidien (10ème édition) (24 novembre 2007: Centre de référence de la mucoviscidose).
99.
Goole, J., Vanderbist, F., & Amighi, K. (2007). Development and evaluation of new multiple-unit sustained-release floating systems. Paper session presented at Journée des sciences pharmaceutiques belges (11 octobre 2007: Spa, Belgique).
100.
Goole, J., Hamdani, J., Vanderbist, F., & Amighi, K. (2006). In vitro and in vivo evaluation in healthy volunteers of a new sustained-release floating dosage form. Poster présenté à la conférence 5th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology.
101.
Goole, J., Hamdani, J., Vanderbist, F., & Amighi, K. (2006). In vitro and in vivo evaluation in healthy volunteers of riboflavin sustained-release floating minitablets. 5th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology Abstract session presented at 5th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology(Geneva)